Revenue, last quarter
$48.8M
+52.3% vs same quarter last year
Net income
−$184.6M
−174.4% vs same quarter last year
EPS, diluted
−$0.18
−157.1% vs same quarter last year
Operating cash flow
−$75.3M
−9.3% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $113.3M | −$351.5M |
| FY24 | $14.7M | −$413.6M |
| FY23 | $622K | −$583.9M |
| FY22 | $240K | −$417.3M |
| FY21 | $934K | −$349.8M |
| FY20 | $605K | −$221.9M |
| FY19 | $2.2M | −$157.8M |
| FY18 | $47K | −$96.2M |
| FY17 | $45K | −$96.4M |
| FY16 | $44K | −$120.8M |
| FY15 | $236K | −$236.9M |
| FY14 | $641K | −$6.2M |
| FY13 | $600K | −$2M |
| FY12 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 99.3% | −226% | −310.3% |
| FY24 | 100% | −2334.2% | −2805% |
| FY23 | 100% | −58239.5% | −93874.6% |
| FY22 | 100% | −146374.2% | −173875% |
| FY21 | - | −35361.9% | −37451.8% |
| FY20 | - | −36509.1% | −36669.6% |
| FY19 | - | −7095.9% | −7165.2% |
| FY18 | - | −209338.3% | −204736.2% |
| FY17 | - | −220266.7% | −214273.3% |
| FY16 | - | −282954.5% | −274565.9% |
| FY15 | - | −101218.6% | −100371.2% |
| FY14 | - | −869.7% | −964.9% |
| FY13 | - | - | −341.2% |
| FY12 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$308.8M |
| FY24 | −$398.1M |
| FY23 | −$397.3M |
| FY22 | −$415.7M |
| FY21 | −$308M |
| FY20 | −$173.4M |
| FY19 | −$156.4M |
| FY18 | −$76.5M |
| FY17 | −$83.6M |
| FY16 | −$45.2M |
| FY15 | −$27.5M |
| FY14 | −$5.7M |
| FY13 | −$671K |
| FY12 | - |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | - |
| FY24 | - |
| FY23 | - |
| FY22 | - |
| FY21 | $0 |
| FY20 | $0 |
| FY19 | $2.5M |
| FY18 | $228K |
| FY17 | $15.2M |
| FY16 | $15.8M |
| FY15 | $4.8M |
| FY14 | $0 |
| FY13 | - |
| FY12 | - |
- ImmunityBio
- Healthcare median
Show the numbers
| Year | ImmunityBio | Healthcare median |
|---|---|---|
| FY25 | −310.3% | −30.6% |
| FY24 | −2805% | −47% |
| FY23 | −93874.6% | −58% |
| FY22 | −173875% | −80.4% |
| FY21 | −37451.8% | −71.9% |
| FY20 | −36669.6% | −62.2% |
| FY19 | −7165.2% | −46.3% |
| FY18 | −204736.2% | −49.6% |
| FY17 | −214273.3% | −45.9% |
| FY16 | −274565.9% | −36% |
| FY15 | −100371.2% | −38.4% |
| FY14 | −964.9% | −35.5% |
| FY13 | −341.2% | −37.1% |
| FY12 | - | −29.1% |